Immunologist with focus on infectious diseases, rare diseases and cancer. I received my PhD in 2012 from the University of Hamburg (Germany) and trained as a postdoctoral fellow at the Ragon Institute of MGH, MIT and Harvard in Cambridge, MA. I have studied T cells in the context of tuberculosis, HIV and melanoma by applying single cell technologies such as flow cytometry and mass cytometry (CyTOF). I am interested in characterizing cellular drug products to better understand their mechanism of action and to identify biomarkers of response. I strive to better serve our patients by understanding the “full picture” of cellular drug products.